Results
20,929 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Geller AdamChief Product Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $233K 1,485 sh | Mar 19, 2026 traded Mar 17, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Geller AdamChief Product Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $233K 1,485 sh | Mar 19, 2026 traded Mar 17, 2026 | |
Capital V LLC10% Owner |
 DSPViant Technology Inc.Open-market sale · 10b5-1 plan |
| SELL |
| $180K 15.0K sh |
| Mar 19, 2026 traded Mar 18, 2026 |
| 22 | Geller AdamChief Product Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $321K 2,094 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 22 | Woolsey Staci MChief Financial Officer |  GVAGRANITE CONSTRUCTION INCOpen-market sale · 10b5-1 plan | SELL | $183K 1,523 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 21 | Larkin Kyle TDirector, President & CEO | GVAGRANITE CONSTRUCTION INC Open-market sale · 10b5-1 plan | SELL | $877K 7,314 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 21 | Tamari ShaharDirector, COO |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $563K 16.7K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER |  STOKStoke Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $86K 2,587 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $191K 6,100 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $117K 3,577 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Beer James ADirector | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 177 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 20 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 19 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $177K 15.0K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 18 | Kelly Patrick ArthurCo-President and COO |  CIFRCipher Digital Inc.Open-market sale · 10b5-1 plan | SELL | $533K 35.6K sh | Mar 19, 2026 traded Mar 16, 2026 |
| 16 | Baroni DarioPresident, IDL |  MCDMCDONALDS CORPOpen-market sale · 10b5-1 plan | SELL | $194K 600 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Peterson JustinChief Technology Officer |  TWTradeweb Markets Inc.Open-market sale · 10b5-1 plan | SELL | $401K 3,212 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Verjus Nathalie Claude OdileCompany Secretary |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $15K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 1,461 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $15K 483 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $3,384 103 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer |  ALABAstera Labs, Inc.Open-market sale · 10b5-1 plan | SELL | $1.10M 8,754 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.02M 7,907 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.81M 13.9K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $2.44M 18.1K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $2.98M 22.3K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $5.75M 43.3K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $3.00M 22.8K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.44M 11.1K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 11 | Wiechmann Andrew C.Chief Financial Officer |  MSCIMSCI Inc.Open-market sale · 10b5-1 plan | SELL | $252K 450 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 9 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $462K 3,624 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 9 | Weingarten TomerDirector, President, CEO |  SSentinelOne, Inc.Open-market sale · 10b5-1 plan | SELL | $562K 38.9K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 9 | Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER |  GKOSGLAUKOS CorpOpen-market sale · 10b5-1 plan | SELL | $62K 625 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 9 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $728K 5,746 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 8 | Chatwani RobertPresident General Mgr, Growth |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $206K 4,300 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 8 | Chatwani RobertPresident General Mgr, Growth | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $200K 4,092 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 8 | Chatwani RobertPresident General Mgr, Growth | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $189K 3,824 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 6 | Tariq MusaDirector |  GHGuardant Health, Inc.Open-market sale · 10b5-1 plan | SELL | $31K 348 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 5 | Rubenstein Andrew H.Director, CEO and President, 10% Owner |  ACELAccel Entertainment, Inc.Open-market sale · 10b5-1 plan | SELL | $44K 3,938 sh | Mar 19, 2026 traded Mar 17, 2026 |